Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 30,882 shares at $8.68 ($268K) on 2024-11-04, disclosed to the SEC on 2024-11-05.
Scheduled sale ($268k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.68 | 15,441 | $134K | 50.0% |
| 2 | $8.68 | 15,441 | $134K | 50.0% |
| Total | $8.68 avg | 30,882 | $268K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |